Local anesthetic with vasoconstrictor combination

This page covers all Local anesthetic with vasoconstrictor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (tetracaine); alpha-2 adrenergic receptors (oxymetazoline).

Targets

Voltage-gated sodium channels (tetracaine); alpha-2 adrenergic receptors (oxymetazoline)

Marketed (1)

• tetracaine HCl and oxymetazoline HCL · Louisiana State University Health Sciences Center in New Orleans · Otolaryngology / Surgery
  This combination drug provides local anesthesia via tetracaine and nasal vasoconstriction via oxymetazoline to reduce bleeding and improve surgical visibility in nasal procedures.

Patent intelligence

• local anesthetic with vasoconstrictor combination patent landscape — aggregated cliff calendar, attackable patents, originator estates